Cargando…
Fluorescent Ligand-Based Discovery of Small-Molecule Sulfonamide Agonists for GPR120
As a critical member of G protein-coupled receptors (GPCRs), G protein-coupled receptor 120 (GPR120) is a potential target for many physiological diseases, such as type 2 diabetes mellitus, inflammation, and obesity. Considering that small-molecule fluorescent ligands can combine the advantages of v...
Autores principales: | Ma, Siyue, Li, Zhenzhen, Yang, Yueli, Zhang, Ling, Li, Minyong, Du, Lupei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8841740/ https://www.ncbi.nlm.nih.gov/pubmed/35174139 http://dx.doi.org/10.3389/fchem.2022.816014 |
Ejemplares similares
-
Discovery of Novel and Selective G-Protein Coupled Receptor 120 (GPR120) Agonists for the Treatment of Type 2 Diabetes Mellitus
por: Wang, Xuekun, et al.
Publicado: (2022) -
GPR120/FFAR4 Pharmacology:
Focus on Agonists in Type
2 Diabetes Mellitus Drug Discovery
por: Carullo, Gabriele, et al.
Publicado: (2021) -
Potential roles of GPR120 and its agonists in the management of diabetes
por: Zhang, Dan, et al.
Publicado: (2014) -
Identification of Crocetin as a Dual Agonist of GPR40 and GPR120 Responsible for the Antidiabetic Effect of Saffron
por: Zhao, Xiaodi, et al.
Publicado: (2023) -
The GPR120 Agonist TUG-891 Inhibits the Motility and Phagocytosis of Mouse Alveolar Macrophages
por: Su, Xing-Li, et al.
Publicado: (2020)